HK1070008A1 - Combination of cytochome p 450 dependent protease inhibitors - Google Patents

Combination of cytochome p 450 dependent protease inhibitors

Info

Publication number: HK1070008A1
Authority: HK; Hong Kong
Prior art keywords: cytochome; combination; protease inhibitors; dependent protease; dependent
Prior art date: 2001-12-12

Application number

HK05102399.8A

Other languages

English (en)

Inventor

Geest Ronald Van Der

Paul Stoffels

Cornelis Groen

Dirk Edward Desire Jochmans

Original Assignee

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-12

Filing date

2005-03-18

Publication date

2005-06-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8181408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1070008(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-03-18 Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd

2005-06-10 Publication of HK1070008A1 publication Critical patent/HK1070008A1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Ultra Sonic Daignosis Equipment (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

HK05102399.8A 2001-12-12 2005-03-18 Combination of cytochome p 450 dependent protease inhibitors HK1070008A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01204841		2001-12-12
PCT/EP2002/014277 WO2003049746A2 (en)	2001-12-12	2002-12-12	Combination of cytochome p450 dependent protease inhibitors

Publications (1)

Publication Number	Publication Date
HK1070008A1 true HK1070008A1 (en)	2005-06-10

Family

ID=8181408

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK05102399.8A HK1070008A1 (en)	2001-12-12	2005-03-18	Combination of cytochome p 450 dependent protease inhibitors

Country Status (28)

Country	Link
US (1)	US20050119338A1 (es)
EP (1)	EP1458447B1 (es)
JP (1)	JP2005511723A (es)
KR (1)	KR100974921B1 (es)
CN (1)	CN100335060C (es)
AR (1)	AR037797A1 (es)
AT (1)	ATE442189T1 (es)
AU (1)	AU2002358713B2 (es)
BR (1)	BR0215043A (es)
CA (1)	CA2469343C (es)
CY (1)	CY1110604T1 (es)
DE (1)	DE60233677D1 (es)
DK (1)	DK1458447T3 (es)
ES (1)	ES2333206T3 (es)
HK (1)	HK1070008A1 (es)
HR (1)	HRP20040619A2 (es)
HU (1)	HUP0402644A3 (es)
IL (1)	IL162353A0 (es)
MX (1)	MXPA04005755A (es)
NO (1)	NO20042666L (es)
NZ (1)	NZ533826A (es)
PL (1)	PL373072A1 (es)
PT (1)	PT1458447E (es)
RU (1)	RU2329050C2 (es)
SI (1)	SI1458447T1 (es)
TW (1)	TWI286476B (es)
WO (1)	WO2003049746A2 (es)
ZA (1)	ZA200404633B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1860107B (zh) *	2003-09-30	2013-08-21	泰博特克药品有限公司	苯并*唑磺酰胺化合物的制备方法及其中间体
US20070104740A1 (en) *	2003-12-23	2007-05-10	Voorspoels Jody Firmin M	Self-microemulsifying drug delivery systems of a hiv protease inhibitor
US7378441B2 (en) *	2004-05-07	2008-05-27	Sequoia Pharmaceuticals, Inc.	Resistance-repellent retroviral protease inhibitors
DK1765337T3 (da) *	2004-07-08	2009-01-05	Tibotec Pharm Ltd	Kombination af tenofovir, ritonavir og TMC114
CA2595295C (en)	2005-02-25	2014-07-08	Tibotec Pharmaceuticals Ltd.	Protease inhibitor precursor synthesis
EP1865967A4 (en) *	2005-04-08	2011-02-09	Chimerix Inc	COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND OTHER DISEASES
AR053845A1 (es) *	2005-04-15	2007-05-23	Tibotec Pharm Ltd	5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
AR057182A1 (es)	2005-11-28	2007-11-21	Tibotec Pharm Ltd	Compuestos de aminofenilsulfonamida sustituida como inhibidores de proteasa del vih
TWI432438B (zh) *	2005-11-28	2014-04-01	Tibotec Pharm Ltd	作為ｈｉｖ蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物及衍生物
SG170795A1 (en) *	2005-12-30	2011-05-30	Gilead Sciences Inc	Methods for improving the pharmacokinetics of hiv integrase inhibitors
JO2841B1 (en) *	2006-06-23	2014-09-15	تيبوتيك فارماسيوتيكالز ليمتد	2-(substituted-amino) -benzothiazole sulfonamide as protease inhibitors HIV (HIV)
WO2008022345A2 (en)	2006-08-18	2008-02-21	Sequoia Pharmaceuticals, Inc.	Compositions and methods for inhibiting cytochrome p450
CN101702908A (zh) *	2007-03-23	2010-05-05	麻萨诸塞州大学	Hiv-1蛋白酶抑制剂
UA103013C2 (uk)	2007-12-06	2013-09-10	Тиботек Фармасьютикелз	Амідні сполуки як активатори противірусних препаратів
GT200800303A (es)	2007-12-24	2009-09-18		Combinacion anti-retroviral
CN105055432A (zh)	2008-01-25	2015-11-18	奇默里克斯公司	治疗病毒感染的方法
AU2009301131B2 (en)	2008-10-07	2014-03-27	Janssen Sciences Ireland Uc	New amide compounds as boosters of antivirals
US8921349B2 (en)	2009-05-11	2014-12-30	Purdue Research Foundation	Compounds and methods for treating AIDS and HIV infections
JO3090B1 (ar) *	2009-12-11	2017-03-15	Janssen Sciences Ireland Uc	5- امينو-4- هيدروكسي-بنتويل اميدات
PL2534150T3 (pl)	2010-02-12	2017-09-29	Chimerix, Inc.	Sposoby leczenia infekcji wirusowej
US9278135B2 (en)	2010-04-26	2016-03-08	Chimerix Inc.	Methods of treating retroviral infections and related dosage regimes
WO2011153192A2 (en) *	2010-06-01	2011-12-08	Angion Biomedica Corp.	Cytochrome p450 inhibitors and uses thereof
PT2729130T (pt)	2011-07-07	2017-12-13	Gilead Sciences Inc	Formulações de combinação de darunavir
HUE030341T2 (en)	2011-07-07	2017-05-29	Janssen Sciences Ireland Uc	Darunavir preparations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995010281A1 (en) *	1993-10-13	1995-04-20	Merck & Co., Inc.	Combination therapy for hiv infection
US6037157A (en) *	1995-06-29	2000-03-14	Abbott Laboratories	Method for improving pharmacokinetics
WO1998005333A1 (en) *	1996-08-05	1998-02-12	Molecumetics Ltd.	Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
US6180634B1 (en) *	1997-11-13	2001-01-30	Merck & Co., Inc.	Combination therapy for the treatment of AIDS
US6436989B1 (en) *	1997-12-24	2002-08-20	Vertex Pharmaceuticals, Incorporated	Prodrugs of aspartyl protease inhibitors
DE69943266D1 (de) *	1998-06-23	2011-04-21	Trustees For The University Of Illinois Board Of	Arzneimittel zur behandlung von hiv-infizierten säugetieren
WO1999067254A2 (en) *	1998-06-23	1999-12-29	The United States Of America Represented By The Secretary, Department Of Health And Human Services	Multi-drug resistant retroviral protease inhibitors and use thereof
MY145265A (en) *	1998-07-20	2012-01-13	Abbott Lab	Amorphous ritonavir
ATE311391T1 (de) *	1999-02-12	2005-12-15	Vertex Pharma	Aspartyl-protease-inhibitoren
US6319946B1 (en) *	1999-02-12	2001-11-20	Vertex Pharmaceuticals Incorporated	Inhibitors of aspartyl protease

2002
- 2002-12-11 AR ARP020104805A patent/AR037797A1/es unknown
- 2002-12-11 TW TW091135882A patent/TWI286476B/zh not_active IP Right Cessation
- 2002-12-12 US US10/498,024 patent/US20050119338A1/en not_active Abandoned
- 2002-12-12 WO PCT/EP2002/014277 patent/WO2003049746A2/en active Application Filing
- 2002-12-12 IL IL16235302A patent/IL162353A0/xx unknown
- 2002-12-12 PL PL02373072A patent/PL373072A1/xx not_active IP Right Cessation
- 2002-12-12 DK DK02793018.9T patent/DK1458447T3/da active
- 2002-12-12 NZ NZ533826A patent/NZ533826A/en not_active IP Right Cessation
- 2002-12-12 BR BR0215043-3A patent/BR0215043A/pt not_active Application Discontinuation
- 2002-12-12 AT AT02793018T patent/ATE442189T1/de not_active IP Right Cessation
- 2002-12-12 ES ES02793018T patent/ES2333206T3/es not_active Expired - Lifetime
- 2002-12-12 SI SI200230865T patent/SI1458447T1/sl unknown
- 2002-12-12 EP EP02793018A patent/EP1458447B1/en not_active Revoked
- 2002-12-12 AU AU2002358713A patent/AU2002358713B2/en not_active Revoked
- 2002-12-12 RU RU2004121144/15A patent/RU2329050C2/ru not_active IP Right Cessation
- 2002-12-12 HU HU0402644A patent/HUP0402644A3/hu unknown
- 2002-12-12 CN CNB028249119A patent/CN100335060C/zh not_active Expired - Fee Related
- 2002-12-12 JP JP2003550795A patent/JP2005511723A/ja active Pending
- 2002-12-12 PT PT02793018T patent/PT1458447E/pt unknown
- 2002-12-12 KR KR1020047008830A patent/KR100974921B1/ko not_active IP Right Cessation
- 2002-12-12 DE DE60233677T patent/DE60233677D1/de not_active Expired - Lifetime
- 2002-12-12 CA CA002469343A patent/CA2469343C/en not_active Expired - Fee Related
2004
- 2004-06-10 ZA ZA200404633A patent/ZA200404633B/en unknown
- 2004-06-14 MX MXPA04005755A patent/MXPA04005755A/es active IP Right Grant
- 2004-06-24 NO NO20042666A patent/NO20042666L/no not_active Application Discontinuation
- 2004-07-07 HR HR20040619A patent/HRP20040619A2/hr not_active Application Discontinuation
2005
- 2005-03-18 HK HK05102399.8A patent/HK1070008A1/xx not_active IP Right Cessation
2009
- 2009-12-09 CY CY20091101283T patent/CY1110604T1/el unknown

Also Published As

Publication number	Publication date
BR0215043A (pt)	2004-11-03
PL373072A1 (en)	2005-08-08
RU2004121144A (ru)	2005-04-20
NO20042666L (no)	2004-09-09
ES2333206T3 (es)	2010-02-18
IL162353A0 (en)	2005-11-20
CN100335060C (zh)	2007-09-05
EP1458447B1 (en)	2009-09-09
PT1458447E (pt)	2009-12-16
DK1458447T3 (da)	2010-01-18
KR100974921B1 (ko)	2010-08-09
NZ533826A (en)	2006-04-28
MXPA04005755A (es)	2004-09-10
WO2003049746A3 (en)	2003-12-31
HUP0402644A2 (en)	2007-02-28
JP2005511723A (ja)	2005-04-28
AR037797A1 (es)	2004-12-01
KR20040071182A (ko)	2004-08-11
RU2329050C2 (ru)	2008-07-20
AU2002358713A1 (en)	2003-06-23
EP1458447A2 (en)	2004-09-22
ATE442189T1 (de)	2009-09-15
US20050119338A1 (en)	2005-06-02
SI1458447T1 (sl)	2010-01-29
HUP0402644A3 (en)	2008-04-28
CN1604803A (zh)	2005-04-06
ZA200404633B (en)	2005-09-01
CA2469343A1 (en)	2003-06-19
CA2469343C (en)	2008-05-13
WO2003049746A2 (en)	2003-06-19
DE60233677D1 (de)	2009-10-22
TW200409624A (en)	2004-06-16
HRP20040619A2 (en)	2005-08-31
TWI286476B (en)	2007-09-11
CY1110604T1 (el)	2015-04-29
AU2002358713B2 (en)	2009-01-29

Publication	Publication Date	Title
HK1070008A1 (en)	2005-06-10	Combination of cytochome p 450 dependent protease inhibitors
GB0125445D0 (en)	2001-12-12	Protease Inhibitors
EP1307203A4 (en)	2005-08-17	PROTEINASE INHIBITOR
GB0130789D0 (en)	2002-02-06	Application of spores
GB0025782D0 (en)	2000-12-06	Use of inhibitors
PL347948A1 (en)	2002-04-22	Serine protease inhibitor
HK1046899A1 (en)	2003-01-30	Inhibitors of aspartyl protease
IL153421A0 (en)	2003-07-06	Protease inhibitors
IL151087A0 (en)	2003-04-10	Protease inhibitors
EP1401453A4 (en)	2005-04-06	PROTEASE INHIBITORS
AU2002348465A1 (en)	2003-05-06	Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease
IL155997A0 (en)	2003-12-23	Protease inhibitors
AU6407701A (en)	2001-12-24	Serine protease inhibitors
GB0123467D0 (en)	2001-11-21	Carbocyclic HIV Protease inhibitors
AU2002305868A1 (en)	2002-12-23	Inhibitors of reggamma
AU2002346812A1 (en)	2003-06-17	Use of 1-phenyl-oxazolidine-2-one compounds as protease m inhibitors
GB0109278D0 (en)	2001-05-30	Enzyme inhibitors
AU2002325108A1 (en)	2003-03-10	Serine protease inhibitor and processes for the preparation thereof
GB0009123D0 (en)	2000-05-31	Protease inhibitor
GB0104691D0 (en)	2001-04-11	Enzyme inhibitor
GB0109166D0 (en)	2001-05-30	Chimeric peptide inhibitors of proteases
AU2002225220A1 (en)	2002-08-06	Acylation of amino-isothiazoles using trialky-aluminium agents
AU2002328906A1 (en)	2003-03-03	Inhibitors of polyq-aggregation
GB0121073D0 (en)	2001-10-24	Inhibitors of complement activation
AU2001244658A1 (en)	2001-10-08	Gamma-secretase-like protease inhibitors

Legal Events

Date	Code	Title	Description
2013-05-10	PS	Patent surrendered
2013-07-26	PS	Patent surrendered